Somareality is a pioneering company at the forefront of cognitive health, leveraging eye-tracking technology to develop digital biomarkers that monitor and assess cognitive processes in ways previously unimaginable. By harnessing the power of advanced eye-tracking algorithms, Somareality creates innovative tools for real-time, non-invasive monitoring of cognitive functions, offering valuable insights into attention, memory, decision-making, and mental well-being.
QurieGen’s innovative platform combines a proprietary and patented method for decoding cellular responses to drugs with AI-driven data science software, offering a powerful solution for the pharmaceutical industry. By leveraging cutting-edge technology, QurieGen aims to create predictive models of disease biology and drug response, significantly reducing the risks associated with traditional drug development. This approach not only accelerates the development process but also reduces costs by enabling more accurate predictions early in the drug discovery process. By making drug development faster, more efficient, and less expensive, QurieGen aims to transform how the industry approaches the creation of new treatments, ultimately improving outcomes for patients.
Therapixel is a leading innovator in medical imaging, specializing in the use of AI to improve the early detection and diagnosis of breast cancer. The company's flagship product, MammoScreen, leverages advanced AI algorithms to automatically detect, locate, and characterize breast cancer in mammography images. This software assists radiologists by providing a reliable reading aid, helping to streamline the process of image interpretation and ensuring critical cases receive the attention they deserve.
Aktiia specializes in developing wearable devices that enable continuous, real-time monitoring of blood pressure, which is critical in managing chronic conditions like hypertension. By leveraging cutting-edge technology, Aktiia empowers both patients and healthcare providers with actionable insights, facilitating early detection of potential health issues and enabling timely interventions.
C12 Quantum Electronics is developing quantum computing technology using carbon nanotubes, which offer high fidelity and stability for quantum bits encoded in single-electron spins. This approach combines the purity of nanotubes with semiconductor techniques to enable scalable, reliable quantum processing. C12 technology use case applications are endless, including drug discovery where carbon nanotubes could accelerate pharmaceutical development by simulating biological systems and speeding up the discovery of new treatments.
Tatum is a blockchain development platform that simplifies the creation and management of blockchain applications. Its key advantage is its ability to write code once and deploy it across multiple blockchains, saving time and resources. The platform abstracts complex blockchain operations into easy-to-use API calls, enabling developers to build applications quickly, even without prior blockchain experience. This makes Tatum a powerful tool for innovation in blockchain-based healthcare solutions, such as secure patient records, telehealth, drug tracking, and clinical trial data sharing.
Neuronix AI Labs reduces computer-vision AI cost and power consumption by more than 95% making large-scale cloud and edge deployments cost-effective and enabling computer-vision applications on end-devices with limited compute or battery power. EXIT: Acquired by Microchip Technology in 2024.
X
Application form
✅ Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
